NCT04001972

Brief Summary

Brief advice combined with active referral to smoking cessation (SC) services increases quitting. We aim to strengthen the effect of combined intervention by using interactive communication technologies and nicotine replacement therapy sampling (NRT-S).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
664

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 12, 2019

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 28, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

August 19, 2019

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 8, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
Last Updated

May 23, 2022

Status Verified

May 1, 2022

Enrollment Period

1.7 years

First QC Date

June 12, 2019

Last Update Submit

May 19, 2022

Conditions

Keywords

tobacco dependence treatmentcombined brief interventionAWARD adviceactive referralnicotine replacement therapyinformation and communication technologies

Outcome Measures

Primary Outcomes (2)

  • Biochemically validated abstinence of NRT-S +IM Apps and Chatbot vs. regular SMS

    NRT-S +IM Apps and Chatbot vs. regular SMS on validated abstinence defined as exhaled carbon monoxide \<4ppm

    At 6-month follow-up

  • Biochemically validated abstinence of NRT-S +IM Apps and Chatbot vs. regular SMS

    NRT-S +IM Apps and Chatbot vs. regular SMS on validated abstinence defined as exhaled carbon monoxide \<4ppm

    At 12-month follow-up

Secondary Outcomes (17)

  • Self-reported 7-day point prevalence abstinence

    At 6-month follow-up

  • Self-reported 7-day point prevalence abstinence

    At 12-month follow-up

  • Self-reported past 24-week continuous abstinence

    At 6-month follow-up

  • Self-reported past 24-week continuous abstinence

    At 12-month follow-up

  • Planned quit day

    At 6-month follow-up

  • +12 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

Brief advice (AWARD model) + NRT-S + IM Apps and Chatbot

Behavioral: Brief advice (AWARD model)Drug: NRT-SBehavioral: IM Apps and Chatbot

Control group

ACTIVE COMPARATOR

Brief advice (AWARD model) + regular SMS

Behavioral: Brief advice (AWARD model)Behavioral: Regular SMS message

Interventions

Ask: smoking habit, quit intention and attempt, smoking reduction intention, previous quitting experience including NRT and SC use. Warn: smokers will be orally warned about the harms of smoking and receive a A5-sized leaflet, which includes some shocking pictures of smoking-related diseases, and SC services information. Advise: smokers will be advised to quit as soon as possible and use NRT or SC services. Refer: smokers will be encouraged to seek SC services for free NRT or other SC services. Those who agreed will be actively referred to their preferred SC services. The collected contact information with consent will be sent to the SC services providers for a quick appointment and follow-up. Do-it-again: Relapsed smokers (identified during follow-ups and IM conversation) will receive the "Advise" and "Refer" intervention.

Also known as: Ask, Warn, Advise, Refer and Do-it-again
Control groupIntervention group
NRT-SDRUG

One-week free NRT (gum or patch) will be provided with dosage based on time to first cigarette smoking after waking up in the morning and previous NRT use (standard practice and according to specific NRT product instructions). Subjects who have first cigarette \<30 minutes in the morning or have previously used NRT, will receive 4mg nicotine gum or 21mg nicotine patch. Those who have first cigarette \>30 minutes after waking up and have not previously used NRT will receive 2mg nicotine gum or 14mg nicotine patch. NRT use and potential side effects will be briefly explained orally based on standardized script according to the product instructions. An NRT use card containing reminders of NRT use and potential side effects will be given.

Also known as: NRT sample
Intervention group

Twelve-week personalized behavioral support will be delivered using interactive communication technologies using (1) regular tailored messages on abstinence, and (2) synchronous IM Apps conversation with trained SC advisors, and (3) a Chatbot: A Chatbot will be built using open source NLP and machine intelligence platforms. The unstructured text data from our previous study (ClinicalTrials.gov ID: NCT03182790) will be used to train the proposed Chatbot. We will draft responses for each identified question. The final version will be incorporated with Application Programming Interface (API) integration into user-friendly apps (iOS/Android/web app) with a backend server support and continuous data collection for potential bigdata analysis.

Intervention group

Regular SMS messages focus on general health and remind the importance of participating in the follow-up surveys and biochemical validation for quitting

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult smokers aged 18+ years who smoke cigarette(s) daily.
  • Exhaled carbon monoxide (CO) level of ≥ 4ppm.
  • Having smartphones and willing to install IM Apps and a Chatbot.
  • Hong Kong residents able to read and communicate in Chinese (Cantonese or Putonghua).

You may not qualify if:

  • Smokers who have psychiatric/psychological diseases/on regular psychotropic medications.
  • Smokers who are using SC medication, NRT, other SC services or projects.
  • Smokers who have contraindication for NRT use: severe angina, arrhythmia, myocardia infraction, pregnancy (or intended to become pregnant \<6 months) or breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Nursing, The University of Hong Kong

Hong Kong, Hong Kong

Location

Related Publications (1)

  • Guo N, Luk TT, Wu YS, Guo Z, Chu JCL, Cheung YTD, Chan CHH, Kwok TTO, Wong VYL, Wong CKH, Lee JJ, Kwok YK, Viswanath K, Lam TH, Wang MP. Effect of mobile interventions with nicotine replacement therapy sampling on long-term smoking cessation in community smokers: A pragmatic randomized clinical trial. Tob Induc Dis. 2023 Mar 24;21:44. doi: 10.18332/tid/160168. eCollection 2023.

MeSH Terms

Conditions

Smoking CessationTobacco Use Cessation

Interventions

Crisis Interventioncorticosteroid hormone-induced factorReferral and Consultation

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and ActivitiesProfessional PracticeOrganization and AdministrationHealth Services Administration

Study Officials

  • Man Ping Wang, PhD

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 12, 2019

First Posted

June 28, 2019

Study Start

August 19, 2019

Primary Completion

May 8, 2021

Study Completion

September 30, 2021

Last Updated

May 23, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations